SEARCH

SEARCH BY CITATION

References

  • Benjamin, R., Khwaja, A., Singh, N., McIntosh, J., Meager, A., Wadhwa, M., Streck, C., Ng, C., Davidoff, A.M. & Nathwani, A.C. (2007) Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. Blood, 109, 12441247.
  • Geng, Y., Yu, D., Blatt, L.M. & Taylor, M.W. (1995) Tumor suppressor activity of the human consensus type I interferon gene. Cytokines and Molecular Therapy, 1, 289300.
  • Ianotto, J.C., Kiladjian, J.J., Demory, J.L., Roy, L., Boyer, F., Rey, J., Dupriez, B., Berthou, C. & Abgrall, J.F. (2009) PEG-IFN-alpha-2a therapy in patients with myelofibrosis: a study of the French Groupe d’Etudes des Myelofibroses (GEM) and France Intergroupe des syndromes Myéloprolifératifs (FIM). British Journal of Haematology, 146, 223225.
  • Kiladjian, J.J., Cassinat, B., Chevret, S., Turlure, P., Cambier, N., Roussel, M., Bellucci, S., Grandchamp, B., Chomienne, C. & Fenaux, P. (2008) Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. Blood, 112, 30653072.
  • Matthews, S.J. & McCoy, C. (2004) Peginterferon alfa-2a: a review of approved and investigational uses. Clinical Therapeutics, 26, 9911025.
  • Mesa, R.A., Li, C.Y., Ketterling, R.P., Schroeder, G.S., Knudson, R.A. & Tefferi, A. (2005) Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood, 105, 973977.
  • Ogawa, H., Tamaki, H., Ikegame, K., Soma, T., Kawakami, M., Tsuboi, A., Kim, E.H., Hosen, N., Murakami, M., Fujioka, T., Masuda, T., Taniguchi, Y., Nishida, S., Oji, Y., Oka, Y. & Sugiyama, H. (2003) The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood, 101, 16981704.
  • Platanias, L.C. (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology, 5, 375386.
  • Rohatiner, A.Z., Balkwill, F.R., Malpas, J.S. & Lister, T.A. (1983) Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML). Cancer Chemotherapy and Pharmacology, 11, 5658.
  • Zhang, C., Cui, G., Chen, Y. & Fan, K. (2007) Antitumor effect of interferon-alpha on U937 human acute leukemia cells in vitro and its molecular mechanism. Journal of Huazhong University of Science and Technology. Medical Sciences, 27, 513515.